We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Cellectricon Announces new Opportunity for the Discovery of Highly Differentiated Therapeutics for Alzheimer’s and Parkinson’s Diseases

Product News   Nov 06, 2018

 
Cellectricon Announces new Opportunity for the Discovery of Highly Differentiated Therapeutics for Alzheimer’s and Parkinson’s Diseases
FURTHER INFORMATION
 
 
 

Related Product News

Industrial Scale Manufacture of Therapeutic Exosomes

Product News

BIA Separations has announced a new solution to help drug-developers overcome critical development bottlenecks in the preparation of exosomes for clinical use.

READ MORE

Nanoform and AstraZeneca Initiate Technology Evaluation

Product News

Nanoform has announced the initiation of a technology evaluation of Nanoform’s Proprietary CESS(R) Technology across a range of AstraZeneca’s proprietary pharmaceutical products.

READ MORE

New Alliance to Support Advancement of Metabolic Phenotyping

Product News

Murdoch University and Bruker have announced a strategic collaboration with the goal of transforming disease prevention and diagnosis, with a focus on metabolic phenotyping.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE